Xero Limited
Xero Limited (XROLF) Financial Performance & Income Statement Overview
Analyze Xero Limited (XROLF) financial statements (income, balance sheet, and cash flow) across both yearly and quarterly periods.
Xero Limited (XROLF) Income Statement & Financial Overview
View the income breakdown for Xero Limited XROLF across both annual and quarterly reports.
Metric | Q4 2025 | Q2 2025 | Q4 2024 | Q2 2024 |
---|---|---|---|---|
Revenue | $1.11B | $995.87M | $913.35M | $793.87M |
Cost of Revenue | $119.87M | $110.53M | $102.65M | $219.57M |
Gross Profit | $986.92M | $885.33M | $810.70M | $574.30M |
Gross Profit Ratio | $0.89 | $0.89 | $0.89 | $0.72 |
R&D Expenses | $349.18M | $299.74M | $310.05M | $153.39M |
SG&A Expenses | $468.51M | $423.30M | $352.17M | $351.86M |
Operating Expenses | $800.66M | $708.95M | $622.58M | $505.25M |
Total Costs & Expenses | $920.53M | $819.48M | $725.23M | $724.82M |
Interest Income | $0.00 | $0.00 | $38.04M | $29.68M |
Interest Expense | $0.00 | $0.00 | $24.08M | $22.24M |
Depreciation & Amortization | -$9.35M | $22.91M | -$11.30M | $125.74M |
EBITDA | $176.91M | $199.30M | $177.70M | $194.79M |
EBITDA Ratio | $0.16 | $0.20 | $0.19 | $0.25 |
Operating Income | $186.26M | $176.38M | $188.12M | $69.05M |
Operating Income Ratio | $0.17 | $0.18 | $0.21 | $0.09 |
Other Income/Expenses (Net) | $21.71M | -$21.68M | -$13.24M | $17.20M |
Income Before Tax | $207.97M | $154.70M | $174.88M | $86.25M |
Income Before Tax Ratio | $0.19 | $0.16 | $0.19 | $0.11 |
Income Tax Expense | $75.24M | $59.61M | $54.44M | $32.55M |
Net Income | $132.72M | $95.09M | $120.44M | $53.70M |
Net Income Ratio | $0.12 | $0.10 | $0.13 | $0.07 |
EPS | $0.87 | $0.62 | $0.72 | $0.35 |
Diluted EPS | $0.85 | $0.62 | $0.72 | $0.35 |
Weighted Avg Shares Outstanding | $155.26M | $153.38M | $152.83M | $151.26M |
Weighted Avg Shares Outstanding (Diluted) | $155.26M | $154.01M | $153.34M | $152.52M |
Over the last four quarters, Xero Limited achieved steady financial progress, growing revenue from $793.87M in Q2 2024 to $1.11B in Q4 2025. Gross profit stayed firm with margins at 89% in Q4 2025 versus 72% in Q2 2024. Operating income totaled $186.26M in Q4 2025, maintaining a 17% margin over recent quarters. Despite shifts in R&D and SG&A costs, EBITDA stayed strong at $176.91M. Net income rose to $132.72M, with EPS at $0.87. Disciplined expense strategies and efficient operations ensured sustained profitability and long-term financial stability.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan